期刊文献+

药物性肝损伤与自身免疫性肝炎的鉴别诊断与治疗策略 被引量:7

Differential diagnosis of drug-induced liver injury and autoimmune hepatitis and related therapeutic strategies
下载PDF
导出
摘要 药物性肝损伤(DILI)与自身免疫性肝炎(AIH)的临床及组织学表现存在较多相似点,给临床医师的鉴别诊断带来困难。通过分别阐述DILI与AIH的关系、临床表现及组织学的异同点,帮助临床医师更好地鉴别DILI与AIH。总结了DILI与AIH治疗方案的选择,尤其着重介绍了在两者鉴别存在困难时,如何根据患者的病情选择不同的治疗策略,最终明确诊断。 Drug-induced liver injury(DILI) and autoimmune hepatitis(AIH) have many similar clinical and histological manifestations,which brings difficulties to clinicians in differential diagnosis. This article elaborates on the association between DILI and AIH and their similarities and differences in clinical and histological manifestations,in order to help clinicians with the differential diagnosis of DILI and AIH.This article reviews the selection of therapeutic regimens for DILI and AIH and introduces how to select therapeutic strategies based on patient conditions and make a definite diagnosis when there are difficulties in differential diagnosis.
作者 卞兆连 邵建国 马雄 BIAN Zhaolian;SHAO Jianguo;MA Xiong(Nantong Institute of Liver Disease,Department of Gastroenterology and Hepatology,Nantong Third People's Hospital,Nantong,Jiangsu 226006,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2018年第6期1156-1159,共4页 Journal of Clinical Hepatology
关键词 药物性肝损伤 肝炎 自身免疫性 诊断 鉴别 治疗 drug - induced liver injury hepatitis autoimmune diagnosis differential therapy
  • 相关文献

参考文献4

二级参考文献40

  • 1张琼华,施光峰,李谦,陈明泉.甘草酸二铵肠溶胶囊治疗慢性肝炎2396例[J].中华传染病杂志,2007,25(3):175-176. 被引量:16
  • 2E.Pukenyte,F.X.Lescure,D.Rey,C.Rabaud,B.Hoen,P.Chavanet,A.P.Laiskonis,J.L.Schmit,T.May,Y.Mouton,Y.Yazdanpanah,马玙,张立兴.HIV感染者抗结核治疗过程中严重肝毒性反应的发生率及其危险因素[J].国际结核病与肺部疾病杂志,2007,2(1):30-35. 被引量:13
  • 3许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:350
  • 4Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH,Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M. Liverinjury from tumor necrosis factor-α antagonists: analysis of thirtyfourcases. Clin Gastroenterol Hepatol 2013; 11: 558-564.e3 [PMID:23333219 DOI: 10.1016/j.cgh.2012.12.025].
  • 5Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G,Vergani D, Vierling JM. Diagnosis and management of autoimmunehepatitis. Hepatology 2010; 51: 2193-2213 [PMID: 20513004 DOI:10.1002/hep.23584].
  • 6Ozorio G, McGarity B, Bak H, Jordan AS, Lau H, Marshall C.Autoimmune hepatitis following infliximab therapy for ankylosingspondylitis. Med J Aust 2007; 187: 524-526 [PMID: 17979620DOI: 10.1097/RHU.0b013e318228bcb6].
  • 7Germano V, Picchianti Diamanti A, Baccano G, Natale E, OnettiMuda A, Priori R, Valesini G. Autoimmune hepatitis associated withinfliximab in a patient with psoriatic arthritis. Ann Rheum Dis 2005;64: 1519-1520 [PMID: 16162908 DOI: 10.1136/ard.2004.032821].
  • 8Marques M, Magro F, Cardoso H, Carneiro F, Portugal R, Lopes J,Costa Santos C. Infliximab-induced lupus-like syndrome associatedwith autoimmune hepatitis. Inflamm Bowel Dis 2008; 14: 723-725[PMID: 17929297 DOI: 10.1002/ibd.20293].
  • 9Adar T, Mizrahi M, Pappo O, Scheiman-Elazary A, ShiboletO. Adalimumab-induced autoimmune hepatitis. J Clin Gastroenterol2010; 44: e20-e22 [PMID: 19593165 DOI: 10.1097/MCG.0b013e3181a745e7].
  • 10Doyle A, Forbes G, Kontorinis N. Autoimmune hepatitis duringinfliximab therapy for Crohn's disease: a case report. J Crohns Colitis2011; 5: 253-255 [PMID: 21575891 DOI: 10.1016/j.crohns.2010.12.007].

共引文献658

同被引文献37

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部